Table 2.

Clinical characteristics of the 4 RS-SCID patients withArtemis gene mutations

PatientSexAge at
diagnosis
DiagnosisConsanguinity of
parents
Infections
at diagnosis
TreatmentOutcome
Artemis-1 5 mo TBNK+ Yes PCP BMT Alive 
Artemis-2 5 mo TlowBNK+* Yes PCP, CMV BMT No B-cell take; receives IVIG 
Artemis-3.1 4 mo TBNK+ No Persistent VZV infection BMT Died from disseminated infections 
Artemis-3.2 1 d TBNK+ No None BMT Died from multiorgan failure 
PatientSexAge at
diagnosis
DiagnosisConsanguinity of
parents
Infections
at diagnosis
TreatmentOutcome
Artemis-1 5 mo TBNK+ Yes PCP BMT Alive 
Artemis-2 5 mo TlowBNK+* Yes PCP, CMV BMT No B-cell take; receives IVIG 
Artemis-3.1 4 mo TBNK+ No Persistent VZV infection BMT Died from disseminated infections 
Artemis-3.2 1 d TBNK+ No None BMT Died from multiorgan failure 

PCP indicates Pneumocystis carinii pneumonia; BMT, BM transplantation; CMV, cytomegalovirus; IVIG, intravenous Ig substitution; and VZV, varicella-zoster virus.

*

Maternal T lymphocytes were shown to be present in her PB but did not cause graft-versus-host disease due to identical HLA.

Close Modal

or Create an Account

Close Modal
Close Modal